DRUG STUDY

St. Mary’s College of Tagum

PATIENTS INITITALS: ______________________________ Age/Gender: _____________ Name of Student: _LARITA, ANNA V._____________________
Complaints: _____________________________________ Physician: _______________________________ Inclusive Dates & Area: _______________________________
Admitting Dx: __________________________________________________________________________________________ CLINICAL INSTRUCTOR: _______________________________
NAME OF CLASSIFICA ROUTE & ONSET OF CONTRAIN SIDE EFFECTS ADVERSE NURSING
INDICATION
DRUG TION FREQUENCY ACTION DICATION EFFECTS CONSIDERATION
DEXAMETHASO Corticosteroid Anti-Inflammatory Inhibits Acute Hypersensiti Frequent: Inhalation: Long-term therapy: BASELINE ASSESSMENT
NE s PO, IV, IM: accumulation of exacerbations of vity; active Cough, dry mouth, Muscle wasting Question for
ADULTS, ELDERLY: inflammatory chronic allergic untreated hoarseness, throat (esp. arms, legs), hypersensitivity to any
0.75–9 mg/ day in cells at disorders, infections; irritation. Intranasal: osteoporosis, corticosteroids. Obtain
divided doses q6– inflammation cerebral edema, ophthalmic Burning, mucosal spontaneous baselines for height,
12h. sites, conditions use in viral, dryness. Ophthalmic: fractures, weight, B/P, serum
CHILDREN: 0.08–0.3 phagocytosis, treated by fungal Blurred vision. Systemic: amenorrhea, glucose, electrolytes.
mg/kg/day in lysosomal immunosuppress disease of Insomnia, facial edema cataracts, glaucoma, INTERVENTION/
divided doses q6– enzyme release ion, the eye. (cushingoid appearance peptic ulcer disease, EVALUATION
12h. and synthesis, inflammatory [“moon face”]), CHF. Ophthalmic: Monitor I&O, daily weight.
and/or release of conditions, otitis moderate abdominal Glaucoma, ocular Assess for edema.
Cerebral Edema mediators of externa, distention, indigestion, hypertension, Evaluate food tolerance.
IV: ADULTS, inflammation. ophthalmic increased appetite, cataracts. Abrupt Monitor daily pattern of
ELDERLY: Initially, 10 Therapeutic conditions nervousness, facial withdrawal bowel activity, stool
mg, then 4 mg (IV or Effect: (corneal injury, flushing, diaphoresis. following long-term consistency. Report
IM) q6h. Prevents/suppres inflammatory Occasional: Inhalation: therapy: Severe hyperacidity promptly.
PO, IV, IM: ses cell/tissue conditions, Localized fungal joint pain, severe Check vital signs at least
CHILDREN: Loading immune allergic infection (thrush). headache, anorexia, twice a day. Be alert to
dose of 1–2 mg/kg, reactions, conjunctivitis). Intranasal: Crusting nausea, fever, infection (sore throat,
then 1–1.5 inflammatory inside nose, epistaxis, rebound fever, vague symptoms).
mg/kg/day in process. sore throat, ulceration inflammation, Monitor serum
divided doses q4– of nasal mucosa. fatigue, weakness, electrolytes, esp. for
6h. Ophthalmic: Decreased lethargy, dizziness, hypercalcemia (muscle
vision; watering of eyes; orthostatic twitching, cramps),
Nausea/Vomiting in eye pain; burning, hypotension. hypokalemia (weakness,
Chemotherapy Pts stinging, redness of muscle cramps,
IV: ADULTS, eyes; nausea; vomiting. NEONATE: paresthesia [esp. lower
ELDERLY: 8–20 mg Systemic: Dizziness, In preterm infants, extremities],
once, then 4 mg decreased/ blurred early administration nausea/vomiting,
(PO, IM, IV) q4–6h. vision. Rare: Inhalation: of dexamethasone irritability), Hgb, occult
CHILDREN: 10 Increased at a moderate dose blood loss. Assess
mg/m2 /dose bronchospasm, has no effect on emotional status, ability to
(Maximum: 20 mg), esophageal candidiasis. death or chronic sleep. PATIENT/FAMILY
then 5 mg/m2 /dose Intranasal: lung disease and is TEACHING
q6h. Nasal/pharyngeal associated • Do not change
Physiologic candidiasis, eye pain. with gastrointestinal dose/schedule or stop
Replacement PO, IV, Systemic: Generalized perforation and taking drug.
IM: ADULTS, allergic reaction (rash, decreased growth. • Must taper off gradually
ELDERLY, CHILDREN: urticaria); pain, redness, under medical
0.03–0.15 swelling at injection site; supervision.
mg/kg/day in psychological changes; • Notify physician if fever,
divided doses q6– false sense of wellbeing; sore throat, muscle aches,
12h. Usual hallucinations; sudden weight gain,
Ophthalmic Dosage, depression edema, exposure to
Ocular Inflammatory measles/chickenpox
Conditions occurs.
Suspension: • Severe stress (serious
ADULTS, ELDERLY, infection, surgery, trauma)
CHILDREN: Initially, may require increased
2 drops q1h while dosage.
awake and q2h at • Inform dentist, other
night for 1 day, then physicians of
reduce to 3–4 times dexamethasone therapy
a day now or within past 12
mos.
• Avoid alcohol, limit
caffeine.